Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial

Authors: Bruno François, Emmanuelle Mercier, Céline Gonzalez, Karim Asehnoune, Saad Nseir, Maud Fiancette, Arnaud Desachy, Gaëtan Plantefève, Ferhat Meziani, Paul-André de Lame, Pierre‐François Laterre, for the MASTER 1 study group, Marc Clavel, Philippe Vignon, Nicolas Pichon, Thomas Daix, Anne-Laure Fedou, Olivier Barraud, Michelle Nouaille, Paul Bourzeix, Séverine Laleu, Pierre-François Dequin, Antoine Guillon, Stephan Ehrmann, Denis Garot, Annick Legras, Véronique Siméon Vieules, Christine Mabillat, Aurélie Aubrey, Antoine Roquilly, Raphaël Cinotti, Pierre-Joachim Mahé, Dominique Demeure, Albane Soria, Delphine Flattrès, Gwenhaël Colin, Aihem Yehia, Jean-Claude Lacherade, Isabelle Vinatier, Christine Lebert, Yolaine Alcourt, Natacha Maguigneau, Vanessa Zinzoni, Marie-Anne Fally, Laurence Robin, Olivier Pajot, Emmanuelle Boitrou, Raphaël Favory, Julien Poissy, Anahita Rouze, Claire Delcourte, Yannick Rabouel, Julie Helms, Raphaël Clere-Jehl, Alexandra Monnier, Hamid Merdji, Samir Chenaf, Hayet Allam, Vincenta Franja, Xavier Wittebole, Philippe Hantson, Christine Colienne, Ludovic Gérard, Virginie Montiel, Diego Castanares Zapatero, Suzanne Renard, Marie France Dujardin, Caroline Berghe, Leslie Gielens - Intensive Care Medicine 2018 cited by 109